Clinical Trial Update: Cymbopogon Citratus Gel as Local Drug Delivery Agent in Reducing Matrix Metalloproteinase-8 Levels Intra-crevicularly in the Treatment of Stage II Periodontitis [Phase 4]

View source ↗

Summary

Phase 4 trial assessing Cymbopogon Citratus Gel as a local drug delivery agent to reduce MMP-8 levels intra-crevicularly in treatment of stage II periodontitis.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Periodontitis

Drugs mentioned

• Cymbopogon Citratus Gel

Snippet

Sponsor: Souzy Kamal | Conditions: Periodontitis Chronic Generalized Moderate | Phase 4 | Status: COMPLETED